AAAAAA

   
Results: 1-13 |
Results: 13
ALLERGIC FACTORS ASSOCIATED WITH THE DEVELOPMENT OF ASTHMA AND THE INFLUENCE OF CETIRIZINE IN A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL - FIRST RESULTS OF ETAC(R)
Authors: WARNER JO BUSINCO L CASIMIR G DIEPGEN TL KJELLMAN M KNOL K MENARDO JL NASPITZ C WAHN U AGBOTON C DELONGUEVILLE M DEPATOUL MC MEREDITH S VANDEPAER M ALBERTINI M BOURRIER T BAUER CP FRANZ R BELLON G BODART E BONER A FORTUNATI P BOTEY J MARIN AM CAVAGNI G GARDENGHI M CLIFFORD R GRIFFITH H DARRAS JP DEBENEDICTIS H PAZZELLI P DERAEVE LE KEMPINAIRE A DUTAU G RANCE F EICHLER I RATH R FAUQUERT JL PIOLLET A FOOTE KD GRIFFIOEN RW SMITT JHS VANNIEROP JC GRIMFELD A SAHRAOUI F GUILLET MH GUILLET G GUSTAFSSON D EKHOLM L HAMELTEILLAC D DEPROST Y HUTTEGGER I LABBE A LASOBORREGO MT MESAPALOMINO A LECLERCQFOUCART J HEINRICH V LEVER R WARD G LIPSCHUTZ W LIPSCHUTZ B LORETTE G MARGUET C MASI M SPECCHIA F MEGLIO P LUCENTI P MORETTI MT MOLLER C FORSBERG G MUNOZLOPEZ F GINERMUNOZ MT ORANJE AP WOLKERSTORFER A NEIJENS HJ OUDESLUYSMURPHY AM SUKHAI RN PAUL KP KLETTKE U PETRUS M RHABBOUR M POLLOCK J BAIRDSNELL M PREHN A SEGER R RIDOUT S MATTHEWS S RING J ROBERT J SCHAUER U KOHLER S SELIGMANN R DEBEAUFORT C SIMONS FER SPICAK V STALDER JF PHELINE F STRANNEGARD IL TAIEB A LABREZE C VANDERWOUDE JK VANBIERVLIET JP VIELUF D VONPILGRIM G WILLE S WARNER A YOUNG E
Citation: Jo. Warner et al., ALLERGIC FACTORS ASSOCIATED WITH THE DEVELOPMENT OF ASTHMA AND THE INFLUENCE OF CETIRIZINE IN A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL - FIRST RESULTS OF ETAC(R), Pediatric allergy and immunology, 9(3), 1998, pp. 116-124
EFFECTS OF MELAGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR,ON THROMBIN AND FIBRINOLYTIC ENZYMES
Authors: GUSTAFSSON D ANTONSSON T BYLUND R ERIKSSON U GYZANDER E NILSSON I ELG M MATTSSON C DEINUM J PEHRSSON S KARLSSON O NILSSON A SORENSEN H
Citation: D. Gustafsson et al., EFFECTS OF MELAGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR,ON THROMBIN AND FIBRINOLYTIC ENZYMES, Thrombosis and haemostasis, 79(1), 1998, pp. 110-118
MELAGATRAN, AN ORAL ACTIVE-SITE INHIBITOR OF THROMBIN, PREVENTS OR DELAYS FORMATION OF ELECTRICALLY-INDUCED OCCLUSIVE THROMBUS IN THE CANINE CORONARY-ARTERY
Authors: MEHTA JL CHEN LY NICHOLS WW MATTSSON C GUSTAFSSON D SALDEEN TGP
Citation: Jl. Mehta et al., MELAGATRAN, AN ORAL ACTIVE-SITE INHIBITOR OF THROMBIN, PREVENTS OR DELAYS FORMATION OF ELECTRICALLY-INDUCED OCCLUSIVE THROMBUS IN THE CANINE CORONARY-ARTERY, Journal of cardiovascular pharmacology, 31(3), 1998, pp. 345-351
DETERMINANTS OF TOTAL AND SPECIFIC IGE IN INFANTS WITH ATOPIC-DERMATITIS
Authors: DELONGUEVILLE M TASSET C WARNER JO BUSINCO L CASIMIR G DIEPGEN L KJELLMAN M KNOL K MENARDO JL NASPITZ C WAHN U BELLON G BODART E BORRES M STANNEG IL SALA JB BOURRIER T CAVAGNI G GARDENGHI M CLIFFORD RD ROY P DARRAS JP DEBENEDICTIS FM PAZZELLI P DERAEVE LE KEMPINAIRE A DUTAU G RANCE F EICHLER I FAUQUERT JL LABBE A FIOCCHI A FOLSTERHOLST R FOOTE KD FORTUNATI P GRIFFIOEN RW SMITT JHS VANNIEROP JC GRIMFIELD A SAHRAOUI F GUILLET MH GUSTAFSSON D EKHOLM L HUTTEGGER I LECLERCQFOUCART J LEVER R WARD G LIPSCHUTZ W LORETTE G MARGUET C MARTINEZSANIRENEO M MASI M MINIACI A MEGLIO P LUCENTI P MORETTI T MOLLER C FORSBERG G MUNOZLOPEZ F GINER MT NEGELE K ORANJE AP WOLKERSTORFER AW NEIJENS HJ OUDESLUYSMURPHY AM SUKHAI RN PAUL K KLETTKE U PETRUS M RHABBOUR M POLLOCK I PREHN A RIDOUT S TARIQ SM ROBERT J SCHAUER U RIEGER C SELIGMANN R SIMONS FER SPICAK V FUCHS M STALDER JF PHELINE F TAIEB A LABBE L TEILLACHAMEL D VANDERWOUDE JK VANBIERVLIET JP VIELUF D RING J VONPILGRIM G WILLE S WARNER A YOUNG E
Citation: M. Delongueville et al., DETERMINANTS OF TOTAL AND SPECIFIC IGE IN INFANTS WITH ATOPIC-DERMATITIS, Pediatric allergy and immunology, 8(4), 1997, pp. 177-184
THE IMPORTANCE OF ENZYME-INHIBITION KINETICS FOR THE EFFECT OF THROMBIN INHIBITORS IN A RAT MODEL OF ARTERIAL THROMBOSIS
Authors: ELG M GUSTAFSSON D DEINUM J
Citation: M. Elg et al., THE IMPORTANCE OF ENZYME-INHIBITION KINETICS FOR THE EFFECT OF THROMBIN INHIBITORS IN A RAT MODEL OF ARTERIAL THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 2026-2026
MELAGATRAN, A NOVEL LOW-MOLECULAR THROMBIN INHIBITOR EXAMINED IN SEVERAL DEEP VENOUS THROMBOSIS MODELS IN THE RAT
Authors: CARLSSON S NILSSON A BORJESSON I HALVARSSON M ERIKSSON B MATTSSON C GUSTAFSSON D
Citation: S. Carlsson et al., MELAGATRAN, A NOVEL LOW-MOLECULAR THROMBIN INHIBITOR EXAMINED IN SEVERAL DEEP VENOUS THROMBOSIS MODELS IN THE RAT, Thrombosis and haemostasis, 1997, pp. 2031-2031
EFFECTS OF A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, MELAGATRAN,ON THROMBIN AND FIBRINOLYTIC ENZYMES - EVALUATION OF THE SUFFICIENT SELECTIVITY
Authors: GUSTAFSSON D ANTONSSON T BYLUND R ERIKSSON U GYZANDER E NILSSON I ELG M MATTSSON C DEINUM J PERSSON S KARLSSON O NILSSON A SORENSEN H
Citation: D. Gustafsson et al., EFFECTS OF A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, MELAGATRAN,ON THROMBIN AND FIBRINOLYTIC ENZYMES - EVALUATION OF THE SUFFICIENT SELECTIVITY, Thrombosis and haemostasis, 1997, pp. 2032-2032
THE IMPORTANCE OF ENZYME-INHIBITION KINETICS FOR THE EFFECT OF THROMBIN INHIBITORS IN A RAT MODEL OF ARTERIAL THROMBOSIS
Authors: ELG M GUSTAFSSON D DEINUM J
Citation: M. Elg et al., THE IMPORTANCE OF ENZYME-INHIBITION KINETICS FOR THE EFFECT OF THROMBIN INHIBITORS IN A RAT MODEL OF ARTERIAL THROMBOSIS, Thrombosis and haemostasis, 78(4), 1997, pp. 1286-1292
IN-VITRO EFFECTS OF INOGATRAN, A SELECTIVE LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR
Authors: TEGERNILSSON AC BYLUND R GUSTAFSSON D GYZANDER E ERIKSSON U
Citation: Ac. Tegernilsson et al., IN-VITRO EFFECTS OF INOGATRAN, A SELECTIVE LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, Thrombosis research, 85(2), 1997, pp. 133-145
EFFECTS OF INOGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, IN RAT MODELS OF VENOUS AND ARTERIAL THROMBOSIS, THROMBOLYSIS AND BLEEDING-TIME
Authors: GUSTAFSSON D ELG M LENFORS S BORJESSON I TEGERNILSSON AC
Citation: D. Gustafsson et al., EFFECTS OF INOGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, IN RAT MODELS OF VENOUS AND ARTERIAL THROMBOSIS, THROMBOLYSIS AND BLEEDING-TIME, Blood coagulation & fibrinolysis, 7(1), 1996, pp. 69-79
SIGNIFICANCE OF INDOOR ENVIRONMENT FOR THE DEVELOPMENT OF ALLERGIC SYMPTOMS IN CHILDREN FOLLOWED UP TO 18 MONTHS OF AGE
Authors: GUSTAFSSON D ANDERSSON K FAGERLUND I KJELLMAN NIM
Citation: D. Gustafsson et al., SIGNIFICANCE OF INDOOR ENVIRONMENT FOR THE DEVELOPMENT OF ALLERGIC SYMPTOMS IN CHILDREN FOLLOWED UP TO 18 MONTHS OF AGE, Allergy, 51(11), 1996, pp. 789-795
EFFECTS OF INOGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, ON RAT MODELS OF THROMBOSIS
Authors: GUSTAFSSON D ELG M LENFORS S BORJESSON I TEGERNILSSON AC
Citation: D. Gustafsson et al., EFFECTS OF INOGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, ON RAT MODELS OF THROMBOSIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1319-1319
IN-VITRO PROPERTIES OF INOGATRAN, A NEW SELECTIVE LOW-MOLECULAR-WEIGHT INHIBITOR OF THROMBIN
Authors: TEGERNILSSON AC GYZANDER E ANDERSSON S ENGLUND M MATTSSON C ULVINGE JC GUSTAFSSON D
Citation: Ac. Tegernilsson et al., IN-VITRO PROPERTIES OF INOGATRAN, A NEW SELECTIVE LOW-MOLECULAR-WEIGHT INHIBITOR OF THROMBIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1325-1325
Risultati: 1-13 |